Immunization of adults

Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026

Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026

Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13 TeV.

Physical review letters·2026

Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026

Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026

Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026

Same journal

Advances in Multiple Sclerosis.

The New England journal of medicine·2026

Same journal

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

The New England journal of medicine·2026

Same journal

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

The New England journal of medicine·2026

Same journal

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

The New England journal of medicine·2026

Related Experiment Videos

Immunization of adults

Related Concept Videos

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13 TeV.

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Advances in Multiple Sclerosis.

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

Related Experiment Videos

Immunization of adults

Related Concept Videos

Related Articles

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13 TeV.

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Advances in Multiple Sclerosis.

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.